239 related articles for article (PubMed ID: 20682317)
1. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
Baba Y; Nosho K; Shima K; Huttenhower C; Tanaka N; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
Gastroenterology; 2010 Dec; 139(6):1855-64. PubMed ID: 20682317
[TBL] [Abstract][Full Text] [Related]
2. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
[TBL] [Abstract][Full Text] [Related]
3. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
[TBL] [Abstract][Full Text] [Related]
5. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
Ito Y; Koessler T; Ibrahim AE; Rai S; Vowler SL; Abu-Amero S; Silva AL; Maia AT; Huddleston JE; Uribe-Lewis S; Woodfine K; Jagodic M; Nativio R; Dunning A; Moore G; Klenova E; Bingham S; Pharoah PD; Brenton JD; Beck S; Sandhu MS; Murrell A
Hum Mol Genet; 2008 Sep; 17(17):2633-43. PubMed ID: 18541649
[TBL] [Abstract][Full Text] [Related]
6. Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.
Nishihara R; Wang M; Qian ZR; Baba Y; Yamauchi M; Mima K; Sukawa Y; Kim SA; Inamura K; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Schernhammer ES
Am J Clin Nutr; 2014 Dec; 100(6):1479-88. PubMed ID: 25411283
[TBL] [Abstract][Full Text] [Related]
7. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
8. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.
Murrell A; Ito Y; Verde G; Huddleston J; Woodfine K; Silengo MC; Spreafico F; Perotti D; De Crescenzo A; Sparago A; Cerrato F; Riccio A
PLoS One; 2008 Mar; 3(3):e1849. PubMed ID: 18365005
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
Cheng YW; Idrees K; Shattock R; Khan SA; Zeng Z; Brennan CW; Paty P; Barany F
Int J Cancer; 2010 Aug; 127(3):568-77. PubMed ID: 19957330
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
Watanabe H; Higashimoto K; Miyake N; Morita S; Horii T; Kimura M; Suzuki T; Maeda T; Hidaka H; Aoki S; Yatsuki H; Okamoto N; Uemura T; Hatada I; Matsumoto N; Soejima H
FASEB J; 2020 Jan; 34(1):960-973. PubMed ID: 31914674
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
Tian F; Tang Z; Song G; Pan Y; He B; Bao Q; Wang S
Mol Med Rep; 2012 Jun; 5(6):1536-40. PubMed ID: 22427002
[TBL] [Abstract][Full Text] [Related]
13. Specific hypomethylated CpGs at the IGF2 locus act as an epigenetic biomarker for familial adenomatous polyposis colorectal cancer.
Miroglio A; Jammes H; Tost J; Ponger L; Gut IG; El Abdalaoui H; Coste J; Chaussade S; Arimondo PB; Lamarque D; Dandolo L
Epigenomics; 2010 Jun; 2(3):365-75. PubMed ID: 22121898
[TBL] [Abstract][Full Text] [Related]
14. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression.
Ibrahim AE; Arends MJ; Silva AL; Wyllie AH; Greger L; Ito Y; Vowler SL; Huang TH; Tavaré S; Murrell A; Brenton JD
Gut; 2011 Apr; 60(4):499-508. PubMed ID: 21068132
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation trends in the intergenic region of the imprinted IGF2 and H19 genes in cloned cattle.
Curchoe CL; Zhang S; Yang L; Page R; Tian XC
Anim Reprod Sci; 2009 Dec; 116(3-4):213-25. PubMed ID: 19282114
[TBL] [Abstract][Full Text] [Related]
16. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
[TBL] [Abstract][Full Text] [Related]
18. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
[TBL] [Abstract][Full Text] [Related]
19. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
Dammann RH; Kirsch S; Schagdarsurengin U; Dansranjavin T; Gradhand E; Schmitt WD; Hauptmann S
Int J Oncol; 2010 Jan; 36(1):171-9. PubMed ID: 19956846
[TBL] [Abstract][Full Text] [Related]
20. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]